C07D 295/13
To an acyclic saturated chain
Official title: to an acyclic saturated chain
C07D295/13 (To an acyclic saturated chain) appears on 1,437 US grants and 1,065 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,437
- Published applications
- 1,065
- Assignees
- 736
- Inventors
- 4,051
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 26 | 0 |
| 1977 | 27 | 0 |
| 1978 | 21 | 0 |
| 1979 | 20 | 0 |
| 1980 | 25 | 0 |
| 1981 | 21 | 0 |
| 1982 | 19 | 0 |
| 1983 | 7 | 0 |
| 1984 | 23 | 0 |
| 1985 | 13 | 0 |
| 1986 | 19 | 0 |
| 1987 | 18 | 0 |
| 1988 | 18 | 0 |
| 1989 | 18 | 0 |
| 1990 | 26 | 0 |
| 1991 | 28 | 0 |
| 1992 | 25 | 0 |
| 1993 | 33 | 0 |
| 1994 | 27 | 0 |
| 1995 | 49 | 0 |
| 1996 | 35 | 0 |
| 1997 | 51 | 0 |
| 1998 | 35 | 0 |
| 1999 | 38 | 0 |
| 2000 | 37 | 0 |
| 2001 | 26 | 10 |
| 2002 | 43 | 53 |
| 2003 | 39 | 70 |
| 2004 | 32 | 75 |
| 2005 | 36 | 62 |
| 2006 | 46 | 51 |
| 2007 | 39 | 39 |
| 2008 | 29 | 46 |
| 2009 | 23 | 57 |
| 2010 | 36 | 46 |
| 2011 | 29 | 23 |
| 2012 | 39 | 39 |
| 2013 | 31 | 37 |
| 2014 | 31 | 38 |
| 2015 | 28 | 35 |
| 2016 | 31 | 25 |
| 2017 | 34 | 41 |
| 2018 | 21 | 20 |
| 2019 | 30 | 38 |
| 2020 | 24 | 40 |
| 2021 | 30 | 31 |
| 2022 | 27 | 37 |
| 2023 | 19 | 31 |
| 2024 | 24 | 31 |
| 2025 | 19 | 48 |
| 2026 | 12 | 42 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ionizable cationic lipid analog material and use thereof as drug delivery carrier29 Sep 2026US 12,746,288 B2Guangzhou Lide Biomedicine Technology Co., Ltd.
- Lipoxygenase inhibitors22 Sep 2026US 12,741,926 B2SRI International
- Small molecule BAX inhibitors and uses thereof18 Aug 2026US 12,708,621 B2Albert Einstein College of Medicine
- Multi-motif dendrons and their supramolecular structures and uses thereof9 Jun 2026US 12,649,830 B2The Governing Council of the University of Toronto
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- Pyridine-piperazine-based scaffolds as highly potent and selective neurolysin activators1 Oct 2026US 2026/0294897 A1Board of Regents of the University of Nebraska
- Lipid nanoparticle for targeted delivery of therapeutic payloads24 Sep 2026US 2026/0285801 A1Trustees of Tufts College
- Salts and crystalline forms of lm11a31 and methods of use thereof10 Sep 2026US 2026/0263476 A1PharmatrophiX, Inc.
- Aromatic compounds for use as protein phosphatase 2a (pp2a) modulators10 Sep 2026US 2026/0265190 A1Rappta Therapeutics Oy
- Lipid compounds, compositions, and uses thereof20 Aug 2026US 2026/0242346 A1Liberate Bio, Inc.
Most cited
By later US patents
- Lipids and compositions for intracellular delivery of biologically active compounds247US 8,691,750 B2Axolabs GmbH · 2014
- Drug composition containing nucleic acid copolymer208US 5,705,188 ANippon Shinyaku Co., Ltd. · 1998
- Aminoalcohol lipidoids and uses thereof207US 8,450,298 B2Massachusetts Institute of Technology · 2013
- Amphipathic PH sensitive compounds and delivery systems for delivering biologically active compounds149US 5,965,434 A1999
- Ligands for metals and improved metal-catalyzed processes based thereon143US 6,307,087 B1Massachusetts Institute of Technology · 2001